DiaCarta Helps Communities Scale Up Their MPOX Testing Efforts With Its Simple, Reliable, and FDA-EUA-Approved MPOX Testing Kits

UF Innovate | Sid Martin Biotech alum DiaCarta Inc., an experienced in-vitro diagnostics (IVD) company that provided COVID-19 testing kits during the global pandemic, has expanded its focus to MPOX detection and the detection of other infectious diseases.

As the demand for mpox (previously known as monkeypox) detection has surged following the World Health Organization (WHO) declaring a public health emergency of international concern (PHEIC) for the mpox outbreak, DiaCarta is working with distributors and laboratories to get their mpox testing kits into the hands of more doctors and hospitals around the globe so they can detect and treat patients faster.

Read more about DiaCarta Helps Communities Scale Up Their MPOX Testing Efforts With Its Simple, Reliable, and FDA-EUA-Approved MPOX Testing Kits.